BeStock  
Stocks › Biotechnology › RGNX

Regenxbio RGNX

US equityMarket cap rank #3612Biotechnology
$7.16 −$0.02 (-0.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.12 -0.56%
Open$7.00
Prev close$7.18
Day range$6.86 – $7.30
Volume1.06M
Market cap$473.44M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-2.4x
CheapRich

Around its usual level · 50th percentile, 5-year average 0.2x

Price / book3.4x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average 3.4x

#3931 of 5329 stocks by PB (1 = cheapest)

Price / sales3.3x
CheapRich

Below its usual level · 37th percentile, 5-year average 5.4x

#3325 of 5156 stocks by PS (1 = cheapest)

P/E over five years

-12x-2x8x18xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$10.36
Price vs. fair value-30.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.41 – 3.41 81% (pricier than usual) #3931 of 5329 (1 = cheapest)
PE -2.39 -1.94 0.16 50% (cheaper than usual) –
PS 3.28 4.92 5.41 37% (cheaper than usual) #3325 of 5156 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RGNX.

Sign in to join the discussion.

Scroll to Top